Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
Presented here is a protocol to radiolabel cells with a positron emission tomography (PET) radioisotope, 89Zr (t1/2 78.4 h), using a ready-to-use radiolabeling synthon, [89Zr]Zr-p-isothiocyanatobenzyl-desferrioxamine ([89Zr]Zr-DBN). Radiolabeling cells with [89Zr]Zr-DBN allows noninvasive tracking and imaging of administered radiolabeled cells in the body with PET for up to 7 days post-administration.
Stem cell and chimeric antigen receptor (CAR) T-cell therapies are emerging as promising therapeutics for organ regeneration and as immunotherapy for various cancers. Despite significant progress having been made in these areas, there is still more to be learned to better understand the pharmacokinetics and pharmacodynamics of the administered therapeutic cells in the living system. For noninvasive, in vivo tracking of cells with positron emission tomography (PET), a novel [89Zr]Zr-p-isothiocyanatobenzyl-desferrioxamine ([89Zr]Zr-DBN)-mediated cell radiolabeling method has been developed utilizing 89Zr (t1/2 78.4 h). The present protocol describes a [89Zr]Zr-DBN-mediated, ready-to-use, radiolabeling synthon for direct radiolabeling of variety of cells, including mesenchymal stem cells, lineage-guided cardiopoietic stem cells, liver regenerating hepatocytes, white blood cells, melanoma cells, and dendritic cells. The developed methodology enables noninvasive PET imaging of cell trafficking for up to 7 days post-administration without affecting the nature or the function of the radiolabeled cells. Additionally, this protocol describes a stepwise method for the radiosynthesis of [89Zr]Zr-DBN, biocompatible formulation of [89Zr]Zr-DBN, preparation of cells for radiolabeling, and finally the radiolabeling of cells with [89Zr]Zr-DBN, including all the intricate details needed for the successful radiolabeling of cells.
Stem cell and chimeric antigen receptor (CAR) T-cell therapies are gaining popularity and are under active investigation for the treatment of various diseases, such as myocardial failure1,2, retinal degeneration2, macular degeneration2, diabetes2, myocardial infarction3,4,5, and cancers6,7,8,9,
Dendritic cells and melanoma cells were obtained commercially18. Hepatocytes were isolated from the liver of pigs following laparoscopic partial hepatectomy22,24. Stem cells were isolated from bone marrow aspirates18,19,26. The adipose tissue-derived stem cells were obtained from the Human Cellular Therapy Laboratory, Mayo Clinic Rochester23. Human white blood cells were isolated from the collected blood received from the Division of Transfusion Medicine, Mayo Clinic Roc....
The representative results presented in this manuscript were compiled from the previous [89Zr]Zr-DBN synthesis and cell radiolabeling studies18,19,22,23,24,25. In brief, 89Zr can be successfully complexed with DFO-Bn-NCS in ~30-60 min at 25-37 °C using 7.5-15 µg of DFO-Bn-NCS (Table 2
Following are critical steps in the protocol that need optimization for effective cell radiolabeling. In protocol steps 1.2 and 1.3, depending on the volume of [89Zr]Zr(HPO4)2 or [89Zr]ZrCl4 employed, an appropriate volume (microliters) of base must be used; 1.0 M K2CO3 solution must be used for the neutralization of [89Zr]Zr(HPO4)2 and 1.0 M Na2CO3 solution for the neutralization of [8.......
Authors have no financial competing interest but are the inventors of this technology (Patent # US20210330823A1).
This work was supported by NIH 5R21HL127389-02, NIH 4T32HL007111-39, NIH R01HL134664, and DOE DE-SC0008947 grants, International Atomic Energy Agency, Vienna, Mayo Clinic Division of Nuclear Medicine, Department of Radiology, and Mayo Clinic Center for Regenerative Medicine, Rochester, MN. All figures were created using BioRender.com.
....Name | Company | Catalog Number | Comments |
Acetonitrile | Thermo Fisher Scientific, Inc., Waltham, MA, USA | A996-4 | |
Alpha Minimum Essential Medium | Thermo Fisher Scientific, Inc., Waltham, MA, USA | 12571063 | |
Anion exchange column | Macherey-Nagel, Inc., Düren, Germany | 731876 | Chromafix 30-PS-HCO3 SPE 45 mg cartridge |
Conical centrifuge tubes (15 mL) | Corning Inc., Glendale, AZ, USA | 352096 | Falcon 15 mL high-clarity polypropylene (PP) conical centrifuge tubes |
Dendritic cells | The American Type Culture Collection, Manassas, VA, USA | CRL-11904 | |
DFO-Bn-NCS | Macrocyclics, Inc., Plano, TX, USA | B-705 | p-SCN-Bn-Deferoxamine |
DMSO | Sigma-Aldrich, Inc., St. Louis, MO | 276855 | |
Dose calibrator | Mirion Technologies (Capintec), Inc., Florham Park, NJ, USA | 5130-3234 | CRC -55tR Dose Calibrator |
Dulbecco’s modified Eagle’s medium | The American Type Culture Collection, Manassas, VA, USA | 30-2002 | |
Fetal Bovine Serum (FBS) | The American Type Culture Collection, Manassas, VA, USA | 30-2020 | |
Hanks Balanced Salt solution (HBSS) | Thermo Fisher Scientific, Inc., Waltham, MA, USA | 14025092 | For preparation of H-HBSS |
Hydrochloric Acid (trace metal basis grade) | Thermo Fisher Scientific, Inc., Waltham, MA, USA | A508P212 | |
Melanoma cells | The American Type Culture Collection, Manassas, VA, USA | CRL-6475 | |
Methanol | Sigma-Aldrich, Inc., St. Louis, MO | 34860 | |
Microcentrifuge tube | Eppendorf, Hamburg, Germany | 30108442 | Protein LoBind microcentrifuge tube |
Murine GM-CSF | R&D Systems, Inc., Minneapolis, MN USA | 415-ML-010 | |
Penicillin/Streptomycin | Thermo Fisher Scientific, Inc., Waltham, MA, USA | 15140-122 | |
Phosphate Buffered Saline without Ca2+ and Mg2+ | Thermo Fisher Scientific, Inc., Waltham, MA, USA | 10010023 | For washing cells |
Saline | Covidien LLC, Mansfield, MA, USA | 1020 | 0.9% Sterile Saline Solution |
Shaker | Eppendorf, Hamburg, Germany | T1317 | Thermomixer |
Silica gel-rad-TLC paper sheet | Agilent Technologies Inc., Santa Clara, CA, USA | SGI0001 | iTLC-SG |
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaPrzeglądaj więcej artyków
This article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone